…about: Vaccine development: Key milestones and impact of Covid-19 Laboratory tests commonly used to assess vaccines’ efficacy and the benefits of automating them Hamilton standardised and customised solutions for workflows…
…vaccines produced highly comparable results, however while there were no new Covid infections among the Clamp2 volunteers, there have been three Covid cases detected amongst Nuvaxovid recipients so far.” The…
…Reece Armstrong comments on the post-Covid industry landscape. In the second article, Ben Folwell, Principal Consultant at Citeline, maps out how AI, swarm learning and open access to clinical data…
…SARS-CoV-2 infection or Covid-19 vaccination history and those irrespective of these parameters. Each participant received two injections of either GBP510/AS03 or ChAdOx1-S. The researchers found that the immune response induced…
…age group. This study, funded by the Medical Research Council, will test the responses of cells in lymph nodes before and after immunisation with flu and Covid-19 vaccines and compare…
…Covid-19 severity. “Our research indicates that W-ENV contributes to Covid-19 disease severity and may explain manifestations of long Covid,” said Dr Hervé Perron, Chief Scientific Officer of GeNeuro. “This collaboration…
…organisations, ICON is partnering with the US Biomedical Advanced Research and Development Authority on a clinical trial of next-generation Covid-19 vaccine candidates. Joseph R Peterson, PhD, CTO & Co-founder of…
…on the latest industry updates. The buzz with week has been around Phase I trials, with new therapies for lung cancer, geographic atrophy, Parkinson’s, sarcopenia and long Covid demonstrating positive…
…of GBA1 Parkinson’s disease. Could a common antiviral treat long Covid? A UK-based study will investigate whether a common anti-viral medication could double up as a treatment for long Covid….
…body and brain are closely associated with symptoms of long Covid. If treatment demonstrates improvements in these measures, this could lead to improved symptoms for people with long Covid. If…
The UK’s University of Oxford is taking the lead on two collaborative international projects to improve the response to new Covid-19 variants and contribute to future pandemic preparedness. Researchers at…
…for their discoveries that enabled the development of mRNA vaccines against Covid-19. Partners collaborate to unlock the human proteome X-Chem and the Structural Genomics Consortium (SGC) have entered a collaboration…
…vaccinated with a Covid-19 vaccine (and who have not already been vaccinated with a recently updated mRNA Covid-19 vaccine) are eligible to receive one dose and unvaccinated individuals receive two…
…of mRNA vaccines against Covid-19. In a statement, the Assembly said: “The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against Covid-19 during the pandemic…
